BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 14674865)

  • 1. High illumination levels potentiate the acoustic startle response in preweanling rats.
    Weber M; Watts N; Richardson R
    Behav Neurosci; 2003 Dec; 117(6):1458-62. PubMed ID: 14674865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Light-enhanced startle: further pharmacological and behavioral characterization.
    Walker DL; Davis M
    Psychopharmacology (Berl); 2002 Jan; 159(3):304-10. PubMed ID: 11862363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiogenic effects of high illumination levels assessed with the acoustic startle response in rats.
    Walker DL; Davis M
    Biol Psychiatry; 1997 Sep; 42(6):461-71. PubMed ID: 9285082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diazepam suppresses the acquisition but not the expression of 'fear-potentiation' of the acoustic startle response in man.
    Scaife JC; Langley RW; Bradshaw CM; Szabadi E
    J Psychopharmacol; 2005 Jul; 19(4):347-56. PubMed ID: 15982989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amygdaloid GABA, not glutamate neurotransmission or mRNA transcription controls footshock-associated fear arousal in the acoustic startle paradigm.
    Van Nobelen M; Kokkinidis L
    Neuroscience; 2006; 137(2):707-16. PubMed ID: 16289581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of clonidine injections into the bed nucleus of the stria terminalis on fear and anxiety behavior in rats.
    Schweimer J; Fendt M; Schnitzler HU
    Eur J Pharmacol; 2005 Jan; 507(1-3):117-24. PubMed ID: 15659301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latent inhibition of fear potentiated startle in rats.
    Schauz C; Koch M
    Behav Pharmacol; 1998 Mar; 9(2):175-8. PubMed ID: 10065937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of fear-potentiated startle during development: integration of learning and response systems.
    Barnet RC; Hunt PS
    Behav Neurosci; 2006 Aug; 120(4):861-72. PubMed ID: 16893292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of sex and neonatal maternal separation on fear-potentiated and light-enhanced startle.
    de Jongh R; Geyer MA; Olivier B; Groenink L
    Behav Brain Res; 2005 Jun; 161(2):190-6. PubMed ID: 15878207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lateral amygdala processes the value of conditioned and unconditioned aversive stimuli.
    Blair HT; Sotres-Bayon F; Moita MA; Ledoux JE
    Neuroscience; 2005; 133(2):561-9. PubMed ID: 15878802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying fear potentiated startle using absolute versus proportional increase scoring methods: implications for the neurocircuitry of fear and anxiety.
    Walker DL; Davis M
    Psychopharmacology (Berl); 2002 Nov; 164(3):318-28. PubMed ID: 12424556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic mifepristone blocks reconsolidation of cue-conditioned fear; propranolol prevents this effect.
    Pitman RK; Milad MR; Igoe SA; Vangel MG; Orr SP; Tsareva A; Gamache K; Nader K
    Behav Neurosci; 2011 Aug; 125(4):632-8. PubMed ID: 21688892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Favoured genetic background for testing anxiolytics in the fear-potentiated and light-enhanced startle paradigms in the rat.
    Steiner MA; Lecourt H; Rakotoariniaina A; Jenck F
    Behav Brain Res; 2011 Aug; 221(1):34-42. PubMed ID: 21354212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of TRH on acoustic startle, conditioned fear and active avoidance in rats.
    Thompson BL; Rosen JB
    Neuropeptides; 2000 Feb; 34(1):38-44. PubMed ID: 10688967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central CRF receptor antagonist a-helical CRF9-41 blocks reinstatement of extinguished fear: the role of the bed nucleus of the stria terminalis.
    Waddell J; Bouton ME; Falls WA
    Behav Neurosci; 2008 Oct; 122(5):1061-9. PubMed ID: 18823163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological dissociation of moderate and high contextual fear as assessed by freezing behavior and fear-potentiated startle.
    Santos JM; Gárgaro AC; Oliveira AR; Masson S; Brandão ML
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):239-46. PubMed ID: 15695072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats.
    Knoll AT; Meloni EG; Thomas JB; Carroll FI; Carlezon WA
    J Pharmacol Exp Ther; 2007 Dec; 323(3):838-45. PubMed ID: 17823306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lesions of the dorsal hippocampus block trace fear conditioned potentiation of startle.
    Fendt M; Fanselow MS; Koch M
    Behav Neurosci; 2005 Jun; 119(3):834-8. PubMed ID: 15998205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotoxic lesions of the dorsal and ventral hippocampus impair acquisition and expression of trace-conditioned fear-potentiated startle in rats.
    Trivedi MA; Coover GD
    Behav Brain Res; 2006 Apr; 168(2):289-98. PubMed ID: 16413066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-cycloserine and the facilitation of extinction of conditioned fear: consequences for reinstatement.
    Ledgerwood L; Richardson R; Cranney J
    Behav Neurosci; 2004 Jun; 118(3):505-13. PubMed ID: 15174928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.